Early Thursday morning, Apple announced $ 10 million in advanced manufacturing funding and assistance with the design of manufacturing machines for the manufacturer of test kit collection equipment COVID-19 COPAN Diagnostics.
COPAN manufacturing test kit for COVID-19
COPAN Diagnostics is a market leader in sample collection kits which play an essential role in COVID-19 tests. Apple says the funding will allow the company “to quickly accelerate its supply of sample collection kits for hospitals in the United States, increasing production from several thousand today to more than one million kits per week early July “.
The funding will support the expansion of COPAN Diagnostics into a larger facility in southern California with advanced equipment that Apple will help design. More than 50 jobs are expected to be created through funding and the occupation of the new plant.
“We feel a deep sense of responsibility to do everything we can to help healthcare workers, patients and communities support the global response to COVID-19,” said Apple chief operating officer Jeff Williams. “COPAN is one of the world’s most innovative manufacturers of COVID-19 test collection kits, and we are delighted to partner with them so that they can grow as we work to resolve this critical issue for our nation. I couldn’t be more proud of our teams for putting all their energy, passion and innovative spirit at the service of the country’s COVID-19 response. “
Manufacturing equipment used by COPAN Diagnostics to assemble COVID-19 diagnostic collection kits
The company manufactures the swabs and glassware required to collect and process the sinus samples from patients who may be suffering from the disease. In addition, the company’s products are the main means of transport not only for the collection, but also for the transport and long-term preservation of samples.
“We are delighted to forge this new relationship with Apple, whose teams are also making a huge difference in our efforts to increase production of our sample collection and transport kits,” said COPAN Diagnostics CEO Norman Sharples. . “The collection and transport kits are an essential element in the fight against COVID-19. At COPAN, we are delighted and grateful for this partnership with Apple, because our strong convictions in terms of innovation, quality and manufacturing and design excellence are perfectly aligned. Apple’s operational expertise will help us increase the delivery of important pre-analytical tools to healthcare professionals across the country at this critical time. “
Apple CEO Tim Cook announced the Advanced Manufacturing Fund on April 3, 2017. The fund goes beyond Apple’s $ 1 billion investment in SoftBank’s Vision Fund, a $ 100 billion resource created to accelerate the development of technology around the world. About $ 50 billion from the Vision Fund will be spent on American activities.
Glass maker Apple Corning was the first winner of the fund. This first amount of $ 200 million was granted in May 2017.